The RPA Basics and Introduction to UiPath course offers a comprehensive introduction to Robotic Process Automation (RPA) and the UiPath platform, making it ideal for beginners. Starting with the ...

UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Is UiPath stock a buy? Shares trade at a forward price-to-sales ratio of 4.3 based on this year's analyst estimates, but after taking out its $1.6 billion in net cash, it trades at a ratio of ...

We recently published a list of These 10 Stocks Already Sank in June. In this article, we are going to take a look at where UiPath Inc. (NYSE:PATH) stands against other worst performers on Monday.

UiPath (NYSE: PATH) is a global leader in agentic automation, empowering enterprises to harness the full potential of AI agents to autonomously execute and optimize complex business processes.

UiPath (PATH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Omega Healthcare partnered with UiPath to automate medical billing and other administrative tasks. The revenue cycle management company has saved employees hours with its AI document-processing ...

On May 30, Bank of America Securities analyst Bradley Sills raised his price target on UiPath Inc. (NYSE:PATH) to $12 from $10, while reiterating an Underperform rating on the stock.

Facing activist investors and an unsolicited bid of nearly $50 billion from Canadian retailer Alimentation Couche-Tard (ACT), Seven & i Holdings, owner of the 7-Eleven convenience store chain ...